182 related articles for article (PubMed ID: 18001)
1. Update on drug treatment of Parkinsonism.
Winkelman AC
Am Fam Physician; 1977 Jul; 16(1):118-20. PubMed ID: 18001
[No Abstract] [Full Text] [Related]
2. Drugs for parkinsonism.
Med Lett Drugs Ther; 1986 Jun; 28(716):62-4. PubMed ID: 3713639
[No Abstract] [Full Text] [Related]
3. Drugs for parkinsonism.
Med Lett Drugs Ther; 1979 May; 21(9):37-8. PubMed ID: 449844
[No Abstract] [Full Text] [Related]
4. Drugs for parkinsonism.
Med Lett Drugs Ther; 1988 Dec; 30(781):113-6. PubMed ID: 3143051
[No Abstract] [Full Text] [Related]
5. How to achieve maximum benefit for the patient with Parkinson's disease.
Greer M
Geriatrics; 1976 Apr; 31(4):89-96. PubMed ID: 4356
[No Abstract] [Full Text] [Related]
6. Pharmacotherapy: problems and practices.
Muenter MD
Clin Neuropharmacol; 1986; 9 Suppl 1():S23-36. PubMed ID: 3708606
[TBL] [Abstract][Full Text] [Related]
7. Update on the treatment of Parkinson's disease.
Wirz D
Conn Med; 1985 Oct; 49(10):633-7. PubMed ID: 3933903
[No Abstract] [Full Text] [Related]
8. [Therapy of Parkinson's disease. Practical criteria of treatment].
Casacchia M; Carolei A; Zamponi A; Agnoli A; Fazio C
Recenti Prog Med; 1976 May; 60(5):567-84. PubMed ID: 14360
[No Abstract] [Full Text] [Related]
9. [Therapy of tparkinson's disease. Clinical and pharmacological viewpoints].
Przuntek H
Med Klin; 1979 Jul; 74(28-29):1077-83. PubMed ID: 39230
[No Abstract] [Full Text] [Related]
10. Therapy of neurologic disorders in the elderly.
Mancall EL; Covington TR; Alonso RJ
Hosp Pract (Off Ed); 1984 Oct; 19(10):106E, 106I, 106L passim. PubMed ID: 6434551
[No Abstract] [Full Text] [Related]
11. Amantadine and a fixed combination of carbidopa and levodopa in parkinsonism: a preliminary report.
Savery F
Curr Ther Res Clin Exp; 1976 Mar; 19(3):337-8. PubMed ID: 817863
[No Abstract] [Full Text] [Related]
12. Treating parkinsonism in the era of levodopa.
McFarland HR
Am Fam Physician; 1975 Sep; 12(3):99-104. PubMed ID: 240264
[No Abstract] [Full Text] [Related]
13. [Drug therapy of parkinsonism].
Teräväinen H; Larsen TA
Duodecim; 1982; 98(11):892-900. PubMed ID: 6125373
[No Abstract] [Full Text] [Related]
14. Recent developments in the treatment of Parkinson's disease.
Greer M
Geriatrics; 1985 Feb; 40(2):34-8, 41. PubMed ID: 2857148
[TBL] [Abstract][Full Text] [Related]
15. Parkinson's disease.
Morley JB
Aust Fam Physician; 1977 Jan; 6(1):29-30, 32, 34-5. PubMed ID: 16582
[TBL] [Abstract][Full Text] [Related]
16. [Current treatment of the Parkinsonian syndrome].
Voiculescu V
Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Neurol Psihiatr Neurochir; 1985; 30(3):161-6. PubMed ID: 2868512
[No Abstract] [Full Text] [Related]
17. Parkinson's disease.
Lieberman AN
Compr Ther; 1986 Mar; 12(3):25-9. PubMed ID: 3486090
[No Abstract] [Full Text] [Related]
18. A comparison of bromocriptine (Parlodel) and levodopa-carbidopa (Sinemet) for treatment of "de novo" Parkinson's disease patients.
Libman I; Gawel MJ; Riopelle RJ; Bouchard S
Can J Neurol Sci; 1987 Nov; 14(4):576-80. PubMed ID: 3319120
[TBL] [Abstract][Full Text] [Related]
19. Bromocriptine in the treatment of Parkinson's disease: a double-blind study against L-dopa/carbidopa.
Gawel M; Riopelle R; Libman I; Bouchard S
Adv Neurol; 1987; 45():535-8. PubMed ID: 3548263
[No Abstract] [Full Text] [Related]
20. Parcopa: a rapidly dissolving formulation of carbidopa/levodopa.
Med Lett Drugs Ther; 2005 Jan; 47(1201):12. PubMed ID: 15706700
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
